$LCID Cashflow Statement | Understand Stock

$LCID

$3.40 -$0.12 (3.41%) Close

$LCID Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of insurance premium
Non-cash operating lease cost
Stock-based compensation
Loss on disposal of property and equipment
Amortization of debt discount
Inventory and firm purchase commitments write-downs
Change in fair value of contingent forward contract liability
Change in fair value of common stock warrant liability
Change in fair value of convertible preferred stock warrant liability
Common Stock Warrant Liability
Total change in fair value of common stock warrant liability
Change in fair value of equity securities of a related party
Change in fair value of derivative liabilities associated with redeemable convertible preferred stock (related party)
Net accretion of investment discounts/premiums
Gain on extinguishment of debt
Other non-cash items

Changes in operating assets and liabilities:
Accounts receivable (including $(62,631), $(22,383), and $(35,526) from a related party for the years ended December 31, 2025, 2024, and 2023, respectively)
Inventory
Financed insurance premium
Prepaid expenses
Other current assets
Other noncurrent assets
Other assets
Accounts payable
Accrued compensation
Operating lease liability
Other current liabilities
Other long-term liabilities (including $4,900, $107,763, and nil associated with a related party for the years ended December 31, 2024, 2023, and 2022, respectively)
Other liabilities (including $2,100, $4,900, and $107,763 associated with a related party for the years ended December 31, 2025, 2024, and 2023, respectively)

Net cash used in operating activities
Cash flows from investing activities:
Purchases of property, equipment, and software
Purchases of property, plant and equipment (including $(225,864), $(164,683), and $(80,511) from a related party for the years ended December 31, 2025, 2024, and 2023, respectively)
Proceeds from sale of property, plant and equipment
Purchases of investments (including $(30,000), $(35,000), and nil from a related party for the years ended December 31, 2025, 2024, and 2023, respectively)
Proceeds from maturities of investments (including $15,000 from a related party for the year ended December 31, 2025, and nil for the years ended December 31, 2024 and 2023)
Proceed from sale of property, equipment, and software
Proceeds from insurance claims
Proceeds from sale of investments
Proceeds from government grant
Other investing activities
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Payments of issuance costs for redeemable convertible preferred stock
Series A Derivative Liability
Series B Derivative Liability
Payments of issuance costs for redeemable convertible preferred stock
Series A Derivative Liability
Series B Derivative Liability
Proceeds from issuance of common stock
Underwriting Agreement
2025 Subscription Agreement
2024 Underwriting Agreement
2024 Subscription Agreement
2023 Underwriting Agreement
2023 Subscription Agreement
Equity Distribution Agreement
Subscription Agreement
2022 Subscription Agreement

Proceeds from short-term insurance financing note
Payments of issuance costs for the 2025 Subscription Agreement
Proceeds from convertible debt
2031 Notes
2030 Notes
Total proceeds from convertible debt
Payment of transaction costs for the issuance of convertible notes
Payment for issuance costs
Convertible Debt
Line of Credit
2031 Notes
2030 Notes
Total payment for issuance costs
Payment for short-term insurance financing note
Payment for capital lease liabilities
Purchase of capped call options
Repurchases of 2026 Notes
Proceeds from borrowings from a related party
Repayment of borrowings to a related party
Proceeds from failed sale-leaseback transaction
Repurchase of Series B convertible preferred stock
Series B
Series C

Proceeds from exercise of stock options
Proceeds from the exercise of public warrants
Payment of transaction costs related to the reverse recapitalization
Proceeds from employee stock purchase plan
Tax withholding payments for net settlement of employee awards
Payments for finance lease liabilities
Payments for credit facility issuance costs
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents, and restricted cash
Beginning cash, cash equivalents, and restricted cash
Ending cash, cash equivalents, and restricted cash
Supplemental disclosure of cash flow information:
Cash paid for interest, net of amounts capitalized
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activity:
Increases (decrease) in accounts payable and accrued liabilities related to property, plant and equipment (including $81,580, $(19,725) and $8,530 associated with a related party for the years ended December 31, 2025, 2024, and 2023, respectively)
Government grant (related party) reflected in property, plant and equipment
Property, plant and equipment and right-of-use assets obtained through leases
Extinguishment of Series B convertible preferred stock included in Additional paid-in capital
Extinguishment of Series B convertible preferred stock included in accrued liabilities
Equity securities obtained through Strategic Technology Arrangement
Issuance of Series D convertible preferred stock upon exercise of preferred stock warrants
Convertible Notes converted into Series D convertible preferred stock
Unamortized Convertible Notes debt issuance cost and debt discount converted into Series D convertible preferred stock
Accrued interest of Convertible Notes converted to Series D convertible preferred stock
Deferred financing cost reclassed to convertible preferred stock
Issuance of Series E convertible preferred stock contingent forward contracts
Settlement of Series E convertible preferred stock contingent forward contract
Capital contribution upon forfeit of Series E awards
Issuance of Series E convertible preferred stock upon settlement of contingent forward contracts
Series D
Series E
Total issuance of Series E convertible preferred stock upon settlement of contingent forward contracts

Issuance of common stock upon conversion of preferred stock in connection with the reverse recapitalization

Comments